Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 73 5
Anakinra  Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022 57 5
Telaprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/01/2021 4 0
Brincidofovir Potential treatment - theoretical effect Experimental Antiviral Aug/08/2020 1 0
Diltiazem Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/21/2020 1 0
Buspirone Potential treatment - theoretical effect Used to treat other disease Antiviral Jul/10/2020 1 0
Apixaban Potential treatment - theoretical effect Used to treat other disease Antiviral Jul/10/2020 1 0
Lenalidomide Potential treatment - theoretical effect Used to treat other disease Antiviral Jul/10/2020 1 0
Pomalidomide Potential treatment - theoretical effect Used to treat other disease Antiviral Jul/10/2020 1 0
Aminoglutethimide Potential treatment - theoretical effect Used to treat other disease Antiviral Jul/10/2020 1 0
Excel (.xslx) CSV (.csv)